Serum Institute of India Seeks DCGI Nod For COVID-19 Vaccine COVOVAX
Serum Institute Receives Approval To Launch Covovax Trials On Children Aged 7-11
Serum Institute Begins Advance Production Of Its Upcoming Second Covid-19 Vaccine Novavax
Serum Institute Likely To Begin Clinical Trial Of Covovax On Children In India From Next Month: Report
Clinical Trials Of Novovax's Covid-19 Vaccine In India At An Advanced State Of Completion: Dr V K Paul
Novovax's Covid Vaccine Shows 90 Per Cent Efficacy In Late-Stage Study; Will Be Produced By SII In India As Covovax
Raw Materials Are Not Needed For Manufacturing Of Covishield, But For Covovax, Serum Institute To US Govt
US And Europe Have Banned Export Of Critical Raw Materials Needed To Manufacture Covid Vaccines: Adar Poonawalla
Serum Institute Begins Phase Two And Three Bridging Trials Of Covid-19 Vaccine Candidate Covovax In India
